Imbrium Therapeutics Achieves Last Patient Last Visit in Clinical Trial of Potential Treatment for Interstitial Cystitis/Bladder Pain Syndrome
Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), has achieved last patient last visit in its Phase 1b study of the investigational drug sunobinop as a potential ...
Neck and shoulder pain in athletes could signal rare syndrome, experts warn
Madness approaches, athletes experiencing neck or shoulder pain are being urged to consider the possibility of thoracic ...